Human intravenous immunoglobulin therapy

Seminars in Veterinary Medicine and Surgery-Small Animal

Volumn 12, Issue 3, 1997, Pages 178-185

  Scott Moncrieff, J Catharine R ^a,b   Reagan, William J ^a  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ANIMAL; ANIMAL DISEASE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD; DOG; DOG DISEASE; HUMAN; IMMUNOLOGY; METHODOLOGY; MYELOFIBROSIS; PASSIVE IMMUNIZATION; REVIEW; THROMBOCYTOPENIA;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANIMALS; AUTOIMMUNE DISEASES; DOG DISEASES; DOGS; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS, INTRAVENOUS; MYELOFIBROSIS; THROMBOCYTOPENIA;

EID: 0031202731     PISSN: 08820511     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1096-2867(97)80031-x     Document Type: Article

References (56)

1. Buckley RH, Schiff RI: The use of intravenous immune globulin in immunodeficiency diseases. N Engl J Med 325:110-117, 1991
2. McCue JP, Hein RH, Tenold R: Three generations of immunoglobulin G preparations for clinical use. Rev Infect Dis 8:S374-S381, 1986
3. Appropriate uses of human immunoglobulin in clinical practice: Memorandum from an IVIS/WHO meeting. Bull World Health Organ 60:43-47, 1982
4. Intravenous immunoglobulin. NIH Consensus Statement 8:1-23, 1990
5. Kaveri S, Dietrich G, Hurez V, et al: Intravenous immunologlobins (IVIg) in the treatment of autoimmune diseases. Clin Exp Immunol 86:192-198, 1991
6. Haeney M: Intravenous immune globulin in primary immunodeficiency. Clin Exp Immunol 97:11-15, 1994
7. Fischer GW: Use of intravenous immune globulin in newborn infants. Clin Exp Immunol 97:73-77, 1994
8. Cometta A, Baumgartner JD, Glauser MP: Polyclonal intravenous immune globulin for prevention and treatment of infections in critically ill patients. Clin Exp Immunol 97:69-72, 1994
9. Yap PL: Does intravenous immune globulin have a role in HIV-infected patients? Clin Exp Immunol 97:59-67, 1994
10. Siadak MF, Kopecky K, Sullivan KM: Reduction in transplant-related complications in patients given intravenous immune globulin after allogeneic marrow transplantation. Clin Exp Immunol 97:53-57, 1994
11. Sullivan KM: Immunoglobulin Therapy in Bone Marrow Transplantation. Am J Med 83:34-45, 1987 (suppl 4A)
12. Sullivan KM, Kopecky KJ, Jacom J, et al: Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med 323:705-712, 1990
13. Hall P: Immunomodulation with intravenous immunoglobulin. Pharmacotherapy 13:564-573, 1993
14. Berkman SA, Lee ML, Gale RP: Clinical uses of intravenous immunoglobulins. Ann Intern Med 112:278-292, 1990
15. Dwyer JM: Manipulating the immune system with immune globulin. N Engl J Med 326:107-116, 1992
16. Bussel JB: The use of intravenous gamma-globulin in idiopathic thrombocytopenia purpura. Clin Immunol Immunopathol 53:S147-S155, 1989
17. Blanchette V, Imbach P, Andrew M, et al: Randomised trial of intravenous immunoglobin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 344:703-708, 1994
18. Imbach PA: Harmful and beneficial antibodies in immune thrombocytopenic purpura. Clin Exp Immunol 97:25-30, 1994
19. Fehr J, Hofmann V, Kappeler U: Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. N Engl J Med 306:1254-1258, 1982
20. Lusher JM, Warrier I: Use of intravenous gamma globulin in children and adolescents with idiopathic thrombocytopenic purpura and other immune thrombocytopenias. Am J Med 83:10-16, 1987 (suppl 4A)
21. Blanchette V, Luke B, Andrew M, et al: A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenia purpura. J Pediatr 123:989-995, 1993
22. Oda H, Honda A, Sugita K, et al: High-dose intravenous intact IgG infusion in refractory autoimmune hemolytic anemia (Evans syndrome). J Pediatr 107:744-746, 1985
23. Besa EC: Rapid transient reversal of anemia and long-term effects of maintenance intravenous immunoglobulin for autoimmune hemolytic anemia in patients with lymphoproliferative disorders. Am J Med 84:691-698, 1988
24. Bjorkholm M: Intravenous immunoglobulin treatment in cytopenic haematological disorders. J Intern Med 234:119-126, 1993
25. Hilgartner MW, Bussel J: Use of intravenous gamma globulins for the treatment of autoimmune neutropenia of childhood and autoimmune hemolytic anemia. Am J Med 83:25-29, 1987 (suppl 4A)
26. Flores G, Cunningham-Rundles C, Newland AC, et al: Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: Results in 73 patients. Am J Hematol 44:237-242, 1993
27. Bussel JP, Hilgartner MW: The use and mechanism of action of intravenous immunoglobulin in the treatment of immune haematologic disease. Br J Haematol 56:1-7, 1984
28. Kurtzberg J, Friedman HS, Chaffee S, et al: Efficacy of intravenous gamma globulin in autoimmune-mediated pediatric blood dyscrasias. Am J Med 83:4-9, 1987 (suppl 4A)
29. Coulam CB, Stern JJ, Bustillo M: Ultrasonographic findings of pregnancy losses after treatment for recurrent pregnancy loss: Intravenous immunoglobulin versus placebo. Fertil Steril 61:248-251, 1994
30. Mazer BD, Gelfand EW: An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma. J Allergy Clin Immunol 87:976-983, 1991
31. Jordan SC, Toyoda M: Treatment of autoimmune diseases and systemic vasculitis with pooled human intravenous immune globulin. Clin Exp Immunol 97:31-38, 1994
32. Heine O, Mueller-Eckhardt G: Intravenous immune globulin in recurrent abortion. Clin Exp Immunol 97:39-42, 1994
33. Van Der Meche FGA: Intravenous immune globulin in the Guillain-Barre syndrome. Clin Exp Immunol 97:43-47, 1994
34. Gajdos P: Intravenous immune globulin in myasthenia gravis. Clin Exp Immunol 97:49-51, 1994
35. Richter C, Schnabel A, Csernok E, et al: Treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis with high-dose intravenous immunoglobulin. Clin Exp Immunol 101:2-7, 1995
36. Newburger J, Takahashi M, Burns J, et al: The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315:341-347, 1986
37. Jordan SC: Intravenous gamma globulin therapy in systemic lupus erythematosus and immune complex disease. Clin Immunol Immunopathol 53:s164-s169, 1989
38. Engle MA, Fatica NS, Bussel JB, et al: Clinical trial of single-dose intravenous gamma globulin in acute Kawasaki disease. Am J Dis Child 143:1300-1304, 1989
39. Burdach SEG, Evers KG, Geursen RG: Treatment of acute idiopathic thrombocytopenic purpura of childhood with intravenous immunoglobulin G: Comparative efficacy of 7S and 5S preparations. J Pediatr 109:770-775, 1986
40. Kimberly RP, Salmon JE, Bussel JB, et al: Modulation of mononuclear phagocyte function by intravenous gamma-globulin. J Immunol 132:745-750, 1984
41. Clarkson SB, Bussel JB, Kimberly RP, et al: Treatment of refractory immune thrombocytopenic purpura with an anti-Fc receptor antibody. N Engl J Med 314:1236-1239, 1986
42. Kaveri S, Mouthon L, Kazatchkine MD: Immunomodulating effects of intravenous immunoglobulin in autoimmune and inflammatory diseases. J Neurol Neurosurg Psychiatry 57:6-8, 1994
43. Rossi F, Kazatchkine MD: Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig. J Immunol 143:4104-4109, 1989
44. Delfraissy JF, Tchernia G, Laurian Y, et al: Suppressor cell function after intravenous gammaglobulin treatment in adult chronic idiopathic thrombocytopenic purpura. Br J Haematol 60:315-322, 1985
45. Engelhard D, Waner JL, Kapoor N, et al: Effect of intravenous immune globulin on natural killer cell activity: Possible association with autoimmune neutropenia and idiopathic thrombocytopenia. J Pediatr 108:77-81, 1986
46. Schreiber AD, Frank MM: Role of antibody and complement in the immune clearance and destruction of erythrocytes. J Clin Invest 51:575-582, 1972
47. Frank MM, Basta M, Fries LF: The effects of intravenous immune globulin on complement-dependent immune damage of cells and tissues. Clin Immunol Immunopathol 62:s82-s86, 1992
48. Scott-Moncrieff JC, Reagan WJ, Snyder PW, et al: Treatment of canine immune-mediated hemolytic anemia with human intravenous immunoglobulin. J Am Vet Med Assoc 210:1623-1627, 1997
49. Feldman B: Demographics of canine immune-mediated haemolytic anaemia in the Southeastern United States. Comp Haematol Int 6:42-45, 1996
50. Kellerman DL, Bruyette D: Intravenous immunoglobulin in canine immune-medated hemolytic anemia. Proceedings of the 14th annual meeting of the Veterinary Cancer Society, 1994, pp 10-11
51. Scott-Moncrieff JCR, Reagan WJ, Glickman LT, et al: Treatment of nonregenerative anemia with human gamma-globulin in dogs. J Am Vet Med Assoc 206:1895-1900, 1995
52. Duhem C, Dicato MA, Ries F: Side-effects of intravenous immune globulins. Clin Exp Immunol 97:79-83, 1994
53. Pasatiempo AM, Kroser JA, Rudnick M, et al: Acute renal failure after intravenous immunoglobulin therapy. J Rheumatol 21:347-349, 1994
54. Ahsan N, Palmer BF, Wheeler D, et al: Intravenous immunoglobulin-induced osmotic nephrosis. Arch Intern Med 154:1985-1987, 1994
55. Dalakas MC: High-dose intravenous immunoglobulin and serum viscosity: Risk of precipitating thromboembolic events. Neurology 44:223-226, 1994
56. Klein MK, Dow SW, Rosychuk RA: Pulmonary thromboembolism associated with immune-mediated hemolytic anemia in dogs: Ten cases (1982-1987). J Am Vet Med Assoc 195:246-250, 1989